Proceed with Confidence

Trigeminal Neuralgia

Carbatrol is more than a seizure medication. It is also approved for the treatment of pain associated with trigeminal neuralgia.

Trigeminal neuralgia (TN) consists of attacks characterized by sudden, excruciating, recurring, stabbing pain affecting the face.

For some, the pain may appear suddenly and disappear just as abruptly. For others, the pain is continuous with sharp, electric-shock-like shooting pains that last several seconds or up to two minutes. Episodes may occur for a few weeks or months and be followed by periods of complete pain remission. Over time, the episodes may become more frequent and the attacks more severe.

TN is more common in women than in men. It can occur at any age, but most often affects people in their 50s.

Causes of Trigeminal Neuralgia

TN is a repetitive disorder affecting the trigeminal nerve, the nerve that conducts sensation from the upper, middle, and lower parts of the face to the brain. The trigeminal nerve has three branches: the mandibular (lower), the maxillary (middle), and the ophthalmic (upper). The lower branch carries sensation from the lower jaw, including the lower teeth, lower lip, side and front of the tongue, lower gums, and part of the ear. The middle branch carries sensation from the upper jaw, upper teeth and gums, upper lip, cheeks, palate, sinuses, temples, and most of the nose. The upper branch carries sensation from the forehead, eyes, and bridge of the nose.

In most people, the cause of TN is unknown, although compression of the trigeminal nerve by tumors or vascular anomalies may rarely produce symptoms. While the mechanism by which the pain occurs is unknown, it may be the result of irritation or stimulation along the nerve, and this in turn may cause the pain. Irritation may also be associated with multiple sclerosis and tumors, which can usually be diagnosed by an MRI.

Fortunately for most patients, TN can often be effectively managed with medication. For patients who do not experience adequate relief from medication, surgery can usually provide long-term resolution of TN symptoms.

Diagnosing Trigeminal Neuralgia

There is no specific test for TN, but the symptoms are different from other types of facial pain. Therefore, a patient's accurate description of the history, location, and type of pain experienced can help lead to an accurate diagnosis.

Typical symptoms include:

  • Short, sharp bursts of pain often described as feeling like an electric shock.
  • Pain triggered by light skin contact such as brushing one's teeth, shaving, or chewing, or changes in temperature.
  • Pain that comes and goes. Periods of intense, sometimes disabling pain are often followed by pain-free periods lasting months or even longer.
  • Attacks that occur while awake; sleep is pain free.

Treating Trigeminal Neuralgia

The first-line treatment option for TN is medication. However, surgical procedures may be used for patients who are unable to take medication or who fail to respond to medication. Sometimes medications may work initially, but over time become ineffective.

Over-the-counter medications normally used for headache and pain do not work on the pain caused by TN. One of the commonly used and prescribed medications is carbamazepine (CBZ). It is extremely important that you follow your doctor's instructions regarding taking your medication. The right CBZ levels are important to help manage symptoms and potential side effects. Fortunately, long-acting forms of CBZ, like Carbatrol, are available to make it easier to maintain your levels of medication.

FACT

Carbatrol Is Approved For the Treatment of Pain Associated With Trigeminal Neuralgia

Carbamazepine, the ingredient in Carbatrol, is one of the commonly used and prescribed medications for Trigeminal
Neuralgia.

Anticonvulsants should be taken in the manner and at the times prescribed by the physician.

Important Safety Information for Patients and Caregivers

  • Carbatrol® contains carbamazepine. If you are currently taking another medication that contains carbamazepine, do not begin taking Carbatrol without discussing this with your healthcare provider.
  • If you are taking any other medications, including oral contraceptives, over-the-counter medications, or herbal products, be sure to inform your healthcare provider, as Carbatrol can interact with other medications.
  • Carbatrol was generally well tolerated in clinical studies. The most common side effects, particularly when first starting on Carbatrol, were dizziness, drowsiness, unsteadiness, nausea, and vomiting.
  • Serious skin disorders have been reported with use of carbamazepine. These skin disorders may be more common in patients of Asian ancestry. Patients of Asian ancestry who have a specific gene (HLA-B*1502) may be at increased risk. Patients of Asian ancestry should be tested for this gene prior to starting Carbatrol.
  • Contact your healthcare provider if you have any unexplained bruising, fever, or infection. Products that contain carbamazepine have been associated with rare but serious types of blood disorders.
  • Carbamazepine can cause fetal harm. Contact your healthcare provider if you are considering becoming pregnant, or are pregnant, in order to discuss the continued benefits and risks.
  • People with a history of bone marrow problems, or who are allergic to carbamazepine, or who are sensitive to tricyclic antidepressants should not take Carbatrol.
  • Certain types of seizures (absence seizures or petit mal) do not appear to be controlled by carbamazepine.

See Important Safety Information for Patients & Caregivers

Carbatrol® is registered in the United States Patent and Trademark Office.

©2008 Shire US Inc., Wayne, PA 19087-5367
(800) 828-2088. All rights reserved.

This site is strictly intended for US residents and is governed solely by US laws and governmental regulations. Please see our online privacy policy for more information.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.

C510 01/04/2008